Company / Total Assets
Axsome Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$689.8M
FY2025
5-year range
$87.8M / $689.8M
FY2021-FY2025
Trend
+21.3%
vs FY2024
Sector context
#110 of 214
Health Care
What the data says
At $690M, Axsome Therapeutics, Inc.'s total assets ranks #110 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $15M in FY2018 to $690M in FY2025.
Based on SEC 10-K filings.
$690M in FY2025 with a 5-year CAGR of +30.0%.
Improved from $588M to $690M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +27.7%
- 5-Year CAGR
- +30.0%
- 10-Year CAGR
- -
Sector benchmark
#110 of 214 in Health CareTop 51% of 214This company $689.8M Sector average $7.5B
▼
-90.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.0%, indicating consistent growth.
- In FY2025, total assets increased 21.3% year-over-year.
- Ranks #110 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $689.8M | +21.3% |
| FY2024 | $568.5M | -3.4% |
| FY2023 | $588.2M | +77.5% |
| FY2022 | $331.5M | +277.6% |
| FY2021 | $87.8M | -52.8% |
| FY2020 | $186.1M | -15.6% |
| FY2019 | $220.5M | +1334.1% |
| FY2018 | $15.4M | -56.7% |
| FY2017 | $35.6M | -7.0% |
| FY2016 | $38.2M | -22.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026